It seems pretty clear that extremities are the next big growth opportunity in orthopedics. Of course, "big" is a relative statement - the market for implants and tools to repair shoulders, elbows, ankles, and feet is only about 10% the size of the market for spine care, and only about 25% of the size of the spinal fusion market. Even so, double-digit market growth tends to attract attention, and that could be a good thing for Tornier (NASDAQ:TRNX) - an extremities-focused small cap with strong share in this emerging market.
Right now, Tornier is still a company in transition. Not only did the company see a rather sudden CEO/CFO change a year ago, but Tornier is also still...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|